First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

The present study investigated the survival benefit of non–anthracycline (ANT)-based vs ANT-based regimens in a large-scale, real-world cohort of patients with extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTCL). Within the China Lymphoma Collaborative Group (CLCG) database (2000-201...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Qi, Shu-Nan, Yang, Yong, Song, Yu-Qin, Wang, Ying, He, Xia, Hu, Chen, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Qiao, Xue-Ying, Wang, Hua, Li, Gao-Feng, Huang, Hui-Qiang, Zhang, Yu-Jing, Zhu, Yuan, Cao, Jian-Zhong, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Xu, Li-Ming, Yuan, Zhi-Yong, Su, Hang, Zhu, Jun, Li, Ye-Xiong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362384/
https://ncbi.nlm.nih.gov/pubmed/32658985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001852
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak